Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1744783

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1744783

Mechanical Circulatory Support Devices

PUBLISHED:
PAGES: 284 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Global Mechanical Circulatory Support Devices Market to Reach US$1.4 Billion by 2030

The global market for Mechanical Circulatory Support Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Ventricular Assist Devices, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$648.0 Million by the end of the analysis period. Growth in the Extracorporeal Membrane Oxygenation segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.2 Million While China is Forecast to Grow at 5.7% CAGR

The Mechanical Circulatory Support Devices market in the U.S. is estimated at US$319.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$274.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Mechanical Circulatory Support Devices Market - Key Trends & Drivers Summarized

Why Are Mechanical Circulatory Support Devices Revolutionizing Heart Failure Treatment?

Mechanical circulatory support (MCS) devices are life-saving technologies designed to support or replace the pumping function of the failing heart in patients with advanced heart failure. These devices-including ventricular assist devices (VADs), total artificial hearts (TAHs), and extracorporeal membrane oxygenation (ECMO) systems-are used as bridge-to-transplant, bridge-to-recovery, or destination therapy in cases where pharmacologic management is no longer sufficient. They play a crucial role in improving survival rates, stabilizing patients during critical periods, and enhancing quality of life for those awaiting cardiac transplants or managing irreversible cardiac decline.

Advances in miniaturization, biocompatibility, and long-term implantability have expanded the indications for MCS use across age groups and comorbidities. For end-stage heart failure patients ineligible for transplant, MCS devices offer a viable long-term treatment option that sustains circulatory function and improves mobility and independence. The increasing prevalence of heart failure due to aging populations, ischemic heart disease, and cardiomyopathies is driving the global clinical demand for MCS technologies.

How Are Engineering Advances and Clinical Integration Enhancing Device Utility?

Recent innovations in mechanical and materials engineering have led to the development of next-generation VADs that are smaller, more durable, and less prone to complications like thrombosis, bleeding, or infection. Continuous-flow pumps, magnetically levitated impellers, and wireless energy transfer systems are redefining patient outcomes by improving hemodynamic stability with reduced surgical burden. Wearable driveline systems and fully implantable prototypes are improving patient mobility and quality of life, facilitating outpatient management and long-term use.

On the clinical front, integration of real-time hemodynamic monitoring, remote telemetry, and AI-assisted data interpretation is enhancing decision-making and post-implantation care. Multidisciplinary heart failure teams, including surgeons, cardiologists, and rehabilitation specialists, are implementing patient-tailored MCS protocols supported by advanced imaging and risk stratification tools. These systemic improvements are reducing hospitalization time, improving recovery outcomes, and expanding adoption in tertiary care centers worldwide.

Which Healthcare Settings and Patient Segments Are Leading Adoption?

Cardiothoracic surgical centers, academic hospitals, and advanced heart failure programs are the primary adopters of MCS devices. In the U.S., Europe, and Japan, where cardiac transplant programs are well established, MCS devices are increasingly used as both pre-transplant and destination therapy. Pediatric cardiac centers are adopting miniaturized MCS systems designed for congenital heart disease and pediatric cardiomyopathies, while emerging economies are deploying ECMO systems in critical care units for reversible cardiac or respiratory failure.

Demand is also growing in emergency and trauma settings, where portable ECMO units are deployed to support cardiac arrest patients or bridge critical interventions. Global cardiac surgery programs, especially in high-income nations, are investing in MCS as part of integrated cardiovascular care strategies. As heart failure becomes a leading cause of morbidity and mortality worldwide, demand for mechanical support devices is expected to rise across a broad spectrum of care settings.

The Growth in the Mechanical Circulatory Support Devices Market Is Driven by Several Factors…

The growth in the mechanical circulatory support devices market is driven by increasing prevalence of chronic and end-stage heart failure, advances in device miniaturization, and expanded clinical adoption of VADs and ECMO in transplant and critical care. Rising numbers of patients awaiting heart transplants, coupled with donor organ shortages, are fueling demand for long-term mechanical support. Clinical guidelines are increasingly endorsing early intervention with MCS, while better patient selection and post-discharge protocols are improving outcomes.

Investments in biocompatible materials, wireless power systems, and fully implantable devices are driving innovation, while healthcare systems are allocating resources to heart failure management infrastructure. Emerging applications in pediatric cardiology and trauma care are also creating new use cases. Furthermore, government funding, FDA fast-track designations, and academic-industry partnerships are accelerating product development pipelines-ensuring long-term global market expansion for MCS technologies.

SCOPE OF STUDY:

The report analyzes the Mechanical Circulatory Support Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps, Artificial Heart); End-Use (Hospitals, Cardiology Centers, Ambulatory Surgery Centers, Specialty Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets S.r.l.
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Product Code: MCP35334

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Mechanical Circulatory Support Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of End-Stage Heart Failure Globally Drives Demand for Mechanical Circulatory Support (MCS) Devices
    • Growing Preference for Ventricular Assist Devices (VADs) as Bridge-to-Transplant Solutions Expands Clinical Adoption
    • Advancements in Miniaturization and Wireless Power Transfer Strengthen the Case for Next-Generation Implantable MCS Systems
    • Improved Patient Survival Rates With Long-Term LVAD Use Encourage Wider Use in Destination Therapy Applications
    • Expansion of Advanced Heart Failure Programs in Hospitals Boosts Institutional Investment in MCS Infrastructure
    • Rising Number of Heart Transplant Candidates Highlights Demand for Durable Bridge-to-Transplant Support Systems
    • OEM Focus on Fully Implantable and Percutaneous Systems Enhances Patient Mobility and Reduces Infection Risks
    • Integration of Remote Monitoring and Telehealth Capabilities Supports Post-Implant Management and Reduces Readmissions
    • Government Reimbursement Policies and Public Health Coverage Expand Patient Access to MCS Devices in Developed Markets
    • Clinical Research Demonstrating Improved Quality of Life Fuels Physician Confidence in Prescribing MCS Therapies
    • Increasing Use of MCS in Pediatric and Congenital Heart Disease Applications Creates New Niche Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mechanical Circulatory Support Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ventricular Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Extracorporeal Membrane Oxygenation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Intra-Aortic Balloon Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Specialty Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!